Mortality and survival of COVID-19

被引:99
作者
Sousa, G. J. B. [1 ]
Garces, T. S. [1 ]
Cestari, V. R. F. [1 ]
Florencio, R. S. [1 ]
Moreira, T. M. M. [1 ]
Pereira, M. L. D. [1 ]
机构
[1] Univ Estadual Ceara, Postgrad Program Clin Care Nursing & Hlth, Fortaleza, Ceara, Brazil
关键词
Brazil; COVID-19; epidemiology; mortality; survival;
D O I
10.1017/S0950268820001405
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
This study aims to identify the risk factors associated with mortality and survival of COVID-19 cases in a state of the Brazilian Northeast. It is a historical cohort with a secondary database of 2070 people that presented flu-like symptoms, sought health assistance in the state and tested positive to COVID-19 until 14 April 2020, only moderate and severe cases were hospitalised. The main outcome was death as a binary variable (yes/no). It also investigated the main factors related to mortality and survival of the disease. Time since the beginning of symptoms until death/end of the survey (14 April 2020) was the time variable of this study. Mortality was analysed by robust Poisson regression, and survival by Kaplan-Meier and Cox regression. From the 2070 people that tested positive to COVID-19, 131 (6.3%) died and 1939 (93.7%) survived, the overall survival probability was 87.7% from the 24th day of infection. Mortality was enhanced by the variables: elderly (HR 3.6; 95% CI 2.3-5.8;P< 0.001), neurological diseases (HR 3.9; 95% CI 1.9-7.8;P< 0.001), pneumopathies (HR 2.6; 95% CI 1.4-4.7;P< 0.001) and cardiovascular diseases (HR 8.9; 95% CI 5.4-14.5;P< 0.001). In conclusion, mortality by COVID-19 in Ceara is similar to countries with a large number of cases of the disease, although deaths occur later. Elderly people and comorbidities presented a greater risk of death.
引用
收藏
页数:6
相关论文
共 14 条
[1]   Real estimates of mortality following COVID-19 infection [J].
Baud, David ;
Qi, Xiaolong ;
Nielsen-Saines, Karin ;
Musso, Didier ;
Pomar, Leo ;
Favre, Guillaume .
LANCET INFECTIOUS DISEASES, 2020, 20 (07) :773-773
[2]  
Brazilian Ministry of Health, COR COVID 19
[3]  
CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P343, DOI [10.15585/mmwr.mm6912e2, 10.15585/mmwr.mm6915e4]
[4]  
Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI [10.3760/cma.j.issn.0254-6450.2020.02.003, 10.46234/ccdcw2020.032]
[5]  
Huang CL, 2020, LANCET, V395, P497, DOI [10.1016/S0140-6736(20)30183-5, 10.1016/S0140-6736(20)30211-7]
[6]   Covid-19: risk factors for severe disease and death [J].
Jordan, Rachel E. ;
Adab, Peymane ;
Cheng, K. K. .
BMJ-BRITISH MEDICAL JOURNAL, 2020, 368
[7]   Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data [J].
Linton, Natalie M. ;
Kobayashi, Tetsuro ;
Yang, Yichi ;
Hayashi, Katsuma ;
Akhmetzhanov, Andrei R. ;
Jung, Sung-mok ;
Yuan, Baoyin ;
Kinoshita, Ryo ;
Nishiura, Hiroshi .
JOURNAL OF CLINICAL MEDICINE, 2020, 9 (02)
[8]   Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy [J].
Onder, Graziano ;
Rezza, Giovanni ;
Brusaferro, Silvio .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (18) :1775-1776
[9]   The immunopathogenesis of sepsis in elderly patients [J].
Opal, SM ;
Girard, TD ;
Ely, EW .
CLINICAL INFECTIOUS DISEASES, 2005, 41 :S504-S512
[10]   Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan [J].
Shi, Yu ;
Yu, Xia ;
Zhao, Hong ;
Wang, Hao ;
Zhao, Ruihong ;
Sheng, Jifang .
CRITICAL CARE, 2020, 24 (01)